Male Hair Loss Could End: Acne Drug Shows 500% Improvement

Irish company Cosmo Pharmaceuticals revealed that clascoterone, an acne drug approved in 2020, significantly restores hair in men with androgenic alopecia. Phase III trials showed up to 539% improvement versus placebo. The topical solution is safe, well-tolerated, and could become the first effective baldness treatment in 30 years if FDA-approved next year.